Chapagain Moti L, Verma Saguna, Mercier Frederic, Yanagihara Richard, Nerurkar Vivek R
Retrovirology Research Laboratory, Department of Tropical Medicine, Medical Microbiology and Pharmacology, Asia-Pacific Institute of Tropical Medicine and Infectious Diseases, University of Hawaii at Manoa, Honolulu, HI 96813, USA.
Virology. 2007 Jul 20;364(1):55-63. doi: 10.1016/j.virol.2007.02.018. Epub 2007 Mar 30.
Although human polyomavirus JC (JCV) is known to cause progressive multifocal leukoencephalopathy (PML) in immunocompromised individuals, the mechanism by which JCV crosses the blood-brain barrier (BBB) remains unclear. To test our hypothesis that cell-free JCV gains entry into the brain by infecting endothelial cells, we inoculated human brain microvascular endothelial (HBMVE) cells with 50 HAU (1.33+/-0.27 x 10(7) genome copies) of JCV(Mad1) and analyzed the expression of early and late viral genes and proteins by immunocytochemistry, quantitative real-time PCR (qPCR), quantitative real-time reverse transcriptase PCR (qRT-PCR) and immunoprecipitation followed by Western blotting. JCV infected and replicated efficiently in HBMVE cells and produced infectious virions several hundred fold higher than the infecting inoculum. HBMVE cells in vitro did not express serotonin receptor 2A (5HT(2A)R), and 5HT(2A)R blockers did not prevent JCV infection of HBMVE cells. Collectively, our data indicate that the productive in vitro infection of HBMVE cells by JCV is independent of 5HT(2A)R.
尽管已知人类多瘤病毒JC(JCV)会在免疫功能低下的个体中引发进行性多灶性白质脑病(PML),但JCV穿越血脑屏障(BBB)的机制仍不清楚。为了验证我们的假设,即游离的JCV通过感染内皮细胞进入大脑,我们用50个血凝单位(1.33±0.27×10⁷个基因组拷贝)的JCV(Mad1)接种人脑血管内皮(HBMVE)细胞,并通过免疫细胞化学、定量实时PCR(qPCR)、定量实时逆转录PCR(qRT-PCR)以及免疫沉淀后进行蛋白质印迹分析早期和晚期病毒基因及蛋白的表达。JCV在HBMVE细胞中高效感染并复制,产生的感染性病毒粒子比感染接种物高出数百倍。体外培养的HBMVE细胞不表达5-羟色胺受体2A(5HT₂AR),并且5HT₂AR阻断剂不能阻止JCV感染HBMVE细胞。总体而言,我们的数据表明JCV对HBMVE细胞的有效体外感染不依赖于5HT₂AR。